Advent Capital Management’s Elevance Health ELV Stock Holding History

Advent Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,000	Closed	-$1.41M	–	218
2019 Q2	$1.41M	Buy	+5,000	New	+$1.37M	0.03%	166
2019 Q1	–	Sell	-1,000	Closed	-$263K	–	223
2018 Q4	$263K	Sell	1,000 -6,300	-86%	-$1.73M	0.01%	183
2018 Q3	$2M	Sell	7,300 -1,000	-12%	-$260K	0.04%	169
2018 Q2	$1.98M	Buy	+8,300	New	+$1.92M	0.04%	175

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Advent Capital Management's ELV Position: Q3 2019 in Review

Advent Capital Management sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 5,000 shares — an estimated $1.41M sold.

Advent Capital Management first reported a position in ELV in Q2 2018 and held it in 4 quarters. The position peaked at $2M in Q3 2018. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

Advent Capital Management reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
Advent Capital Management sold 5,000 Elevance Health shares in Q3 2019, an estimated $1.41M.
Advent Capital Management first reported a position in Elevance Health in Q2 2018 and held it in 4 quarters.
Advent Capital Management's Elevance Health position peaked at $2M in Q3 2018.
1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Advent Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.